SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
142.390 1.91 (1.36%)

NAV as on 31 Jul, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Jun 30, 15)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 114.30 25.33
Aurobindo Pharm Pharmaceuticals 45.13 10.00
Lupin Pharmaceuticals 36.73 8.14
Strides Arcolab Pharmaceuticals 31.14 6.90
Divis Labs Pharmaceuticals 29.20 6.47
Cadila Health Pharmaceuticals 27.98 6.20
Natco Pharma Pharmaceuticals 26.62 5.90
Glenmark Pharmaceuticals 25.50 5.65
Torrent Pharma Pharmaceuticals 25.27 5.60
Sequent Scienti Pharmaceuticals 21.03 4.66
Sector Allocation (Jun 30, 15)
  Sector   % 1-Year
High Low

Pharmaceuticals

92.38 99.60 91.57
Asset Allocation (%) (Jun 30, 15)
Class
%

Equity

92.38

Others / Unlisted

0.00

Debt

0.00

Mutual Funds

N.A

Money Market

0.00

Cash / Call

7.62

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

56.84

Top 10

84.85
Sectors
%

Top 3

92.38
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.